Asset Allocation

As of September 30, 2025.
Type % Net
Cash 9.98%
Stock 32.98%
Bond 57.02%
Convertible 0.00%
Preferred 0.38%
Other -0.37%
View Asset Allocation
Start Trial

Market Capitalization

Large --
Mid --
Small --
No Data Available
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 60.85%    % Emerging Markets: 0.84%    % Unidentified Markets: 38.30%

Americas 57.41%
56.23%
Canada 2.43%
United States 53.80%
1.18%
Colombia 0.75%
As of September 30, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 3.71%
United Kingdom 0.87%
2.80%
Belgium 0.04%
Finland 0.01%
France 1.25%
Germany 0.00%
Ireland 0.11%
Netherlands 0.94%
Norway 0.04%
Switzerland 0.06%
0.03%
Poland 0.03%
0.02%
Israel 0.01%
Greater Asia 0.58%
Japan 0.10%
0.40%
Australia 0.40%
0.07%
Hong Kong 0.06%
Singapore 0.01%
0.00%
Unidentified Region 38.30%

Bond Credit Quality Exposure

AAA 0.11%
AA 20.14%
A 4.98%
BBB 14.86%
BB 25.50%
B 19.52%
Below B 7.75%
    CCC 6.23%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 1.51%
Not Rated 0.10%
Not Available 7.05%
Short Term 0.00%
As of September 30, 2025
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical --
Materials --
Consumer Discretionary --
Financials --
Real Estate --
Sensitive --
Communication Services --
Energy --
Industrials --
Information Technology --
Defensive --
Consumer Staples --
Health Care --
Utilities --
Not Classified --
Non Classified Equity --
Not Classified - Non Equity --
No Data Available
View Region Exposure
Start Trial

Bond Sector Exposure

As of September 30, 2025
Type % Net
Government 22.86%
Corporate 69.54%
Securitized 3.78%
Municipal 0.34%
Other 3.48%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
3.29%
Less than 1 Year
3.29%
Intermediate
66.51%
1 to 3 Years
11.98%
3 to 5 Years
24.58%
5 to 10 Years
29.95%
Long Term
27.88%
10 to 20 Years
1.88%
20 to 30 Years
24.99%
Over 30 Years
1.00%
Other
2.33%
As of September 30, 2025
View Bond Maturity Exposure
Start Trial